Diagnostic and therapeutic value of airway challenges in asthma

Current Allergy and Asthma Reports

Volumn 9, Issue 3, 2009, Pages 247-253

  Cockcroft, Donald W ^a   Davis, Beth E ^b  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; MANNITOL; METHACHOLINE; SODIUM CHLORIDE;

AIRWAY CONSTRICTION; ASTHMA; BRONCHOSPASM; CLINICAL ASSESSMENT; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERVENTILATION; PROVOCATION TEST; REVIEW; SENSITIVITY AND SPECIFICITY; STIMULUS RESPONSE; TOTAL LUNG CAPACITY;

ADENOSINE MONOPHOSPHATE; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTOR AGENTS; HUMANS; MANNITOL; METHACHOLINE CHLORIDE; SALINE SOLUTION, HYPERTONIC;

EID: 64649100473     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-009-0036-z     Document Type: Review

References (49)

1. Tiffeneau R, Beauvallet M: Epreuve de bronchoconstriction et de bronchodilation par aerosols. Bull Acad de Med 1945, 129:165-168.
2. Pauwels R, Joos G, Van der Straeten M: Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 1988, 18:317-321.
3. Cockcroft DW, Berscheid BA, Murdock KY: Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest 1983, 83:751-754.
4. Crapo RO, Casaburi R, Coates AL, et al.: Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000, 161:309-329.
5. Chai H, Farr RS, Froehlich LA, et al.: Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975, 56:323-327.
6. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE: Bronchial reactivity to inhaled histamine: A method and clinical survey. Clin Allergy 1977, 7:235-243.
7. deVries K, Goei JT, Booy-Noord H, Orie NGM: Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy 1962, 20:93-101.
8. Cockcroft DW, Davis BE, Todd DC, Smycniuk AJ: Methacholine challenge: comparison of two methods. Chest 2005, 127:839-844.
9. Prieto L, Ferrer A, Domenech J, Pérez-Francés C: Effect of challenge method on sensitivity, reactivity, and maximal response to methacholine. Ann Allergy Asthma Immunol 2006, 97:175-181.
10. Cockcroft DW, Davis BE: The bronchoprotective effect of inhaling methacholine by using total lung capacity inspirations has a marked influence on the interpretation of the test results. J Allergy Clin Immunol 2006, 17:1244-1248.
11. Hopp RJ, Bewtra AK, Nair NM, Townley RJ: Specificity and sensitivity of methacholine inhalation challenge in normal and asthmatic children. J Allergy Clin Immunol 1984, 74:154-158.
12. Cockcroft DW, Berscheid BA, Murdock KY, Gore BP: Sensitivity and specificity of histamine PC20 measurements in a random selection of young college students. J Allergy Clin Immunol 1992, 89:23-30.
13. Adelroth E, Hargreave FE, Ramsdale EH: Do physicians need objective measurements to diagnose asthma? Am Rev Respir Dis 1986, 134:704-707.
14. Todd DC, Davis BE, Hurst TS, Cockcroft DW: Dosimeter methacholine challenge: Comparison of maximal versus submaximal inhalations. J Allergy Clin Immunol 2004, 114:517-519.
15. Cockcroft DW, HargreavR FE: Airway hyperresponsiveness: relevance of random population data to clinical usefulness. Am Rev Respir Dis 1990, 142:497-500.
16. Pattemore PK, Asher MI, Harrison AC, et al.: The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms. Am Rev Respir Dis 1990, 142:549-554.
17. Holzer K, Anderson SD, Chan HK, Douglass J: Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003, 167:534-537.
18. Ramsdale EH, Roberts RS, Morris MM, Hargreave FE: Differences in responsiveness to hyperventilation and methacholine in asthma and chronic bronchitis. Thorax 1985, 40:422-426.
19. Verma VK, Cockcroft DW, Dosman JA: Airway hyper-responsiveness to inhaled histamine in chronic obstructive airways disease: Chronic bronchitis vs. emphysema. Chest 1988, 94:456-461.
20. Gibson PGE Dolovich J, Denburg J, et al.: Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989, 1:1346-1348.
21. Irwin RS, French CT, Smyrnios NA, Curley FJ: Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treatment cough-variant asthma. Arch Intern Med 1997, 157:1981-1987.
22. Cartier A, Pineau L, Malo J-L: Monitoring of maximum expiratory peak flow rates and histamine inhalation tests in the investigation of occupational asthma. Clin Allergy 1984, 14:193-196.
23. Anderson SD, Argyros GJ, Magnussen H, Holzer K: Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med 2001, 35:344-347.
24. O'Byrne PM, Ryan G, Morris M, et al.: Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am Rev Respir Dis 1982, 125:281-285.
25. Smith CM, Anderson SD: Inhalational challenges using hypertonic saline in asthmatic subjects: A comparison with responses to hyperpnoea, methacholine and water. Eur Respir J 1990, 3:144-151.
26. Polosa R, Holgate ST: AdAnosine bronchoprovocation: a promising marker of allergic inflammation in asthma? Thorax 1997, 52:919-923.
27. Poloso R, Ng WH, Crimi N, et al.: Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 1995, 151:624-629.
28. Anderson SD, Brannan J, Spring J, et al.: A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997, 156:758-765.
29. Brannan JD, Koskela H, Anderson SD, Chew N: Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med 1998, 158:1120-1126.
30. Brannan JD, Gulliksson M, Anderson SD, et al.: Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003, 22:491-496.
31. Brannan JD, Gulliksson M, Anderson SD, et al.: Inhibition of mast cell PGD2 release protects against mannitolinduced airway narrowing. Eur Respir J 2006, 27:944-950.
32. Pizzichini E, Pizzichini MM, Efthimiadis A: Indices of airway inflammation in induced sputum: Reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996, 154:308-317.
33. Avital A, Springer C, Bar-Yishay E, Godfrey S: Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995, 50:511-516.
34. Woolcock AJ, Cheung W, Salome C: Relationship between bronchial responsiveness to propranolol and histamine. Am Rev Respir Dis 1986, 133:A177.
35. van den Berge M, Meijer RJ, Kerstjens HA, et al.: PC20 adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC20 methacholine. Am J Respir Crit Care Med 2001, 163:1546-1550.
36. Choi SH, Kim DK, Yu J, et al.: Bronchial responsiveness to methacholine and adenosine 5′-monophosphate in young children with asthma: their relationship with blood eosinophils and serum eosinophil cationic protein. Allergy 2007, 62:1119-1124.
37. Porsbjerg C, Brannan JD, Anderson SD, Backer V: Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy 2008, 38:43-50.
38. Porsbjerg C, Rasmussen L, Thomsen SF, et al.: Responses to mannitol in asymptomatic subjects with airway hyperresponsiveness to methacholine. Clin Exp Allergy 2007, 37:22-28.
39. Kim DK, Choi SH, Yu J, et al.: Bronchial responsiveness to methacholine and adenosine 5′-monophosphate in atopic and non-atopic preschool children with recurrent wheezing. Clin Exp Allergy 2007, 37:15-21.
40. van Velzen E, van den Bos JW, Benckhuijsen JA, et al.: Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996, 51:582-584.
41. van den Berge M, Kerstjens HA, Meijer RJ, et al.: Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med 2001, 164:1127-1132.
42. Prosperini G, Rajakulasingam K, Cacciola RR, et al.: Changes in sputum counts and airway hyperresponsiveness after budesonide: Monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation. J Allergy Clin Immunol 2002, 110:855-861.
43. Leupi JD, Tandjung R, Anderson SD, et al.: Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept. Pulm Pharmacol Ther 2005, 18:83-88.
44. Juniper EF, Frith PA, Hargreave FE: Airways responsiveness to histamine and methacholine: Relationship to minimum treatment to control symptoms of asthma. Thorax 1981, 36:575-579.
45. Murray AB, Ferguson AC, Morrison B: Airway responsiveness to histamine as a test for overall severity of asthma in children. J Allergy Clin Immunol 1981, 68:119-124.
46. Green RH, Brightling CE, McKenna S, et al.: Asthma exacerbations and sputum eosinophil counts: A randomized controlled trial. Lancet 2002, 360:1715-1721.
47. Smith AD, Cowan JO, Brassett KP, et al.: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005, 352:2163-2173.
48. Sont JK, Willems LN, Bel EH, et al.: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999, 159:1043-1051.
49. Brannan JD, Koskela H, Anderson SD, Chan HK: Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002, 7:37-44.